HIGH POINT, N.C. (AP) _ VTv Therapeutics Inc. (VTVT) on Friday reported a loss of $3.1 million in its second quarter.

On a per-share basis, the High Point, North Carolina-based company said it had a loss of 31 cents. Losses, adjusted for non-recurring costs, came to 29 cents per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The biopharmaceutical company posted revenue of $2.5 million in the period, meeting Street forecasts.

The company's shares closed at $1.32. A year ago, they were trading at $4.39.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VTVT at https://www.zacks.com/ap/VTVT